The course of neuropsychiatric symptoms in dementia.
Part I: findings from the two-year longitudinal Maasbed study. Int J Geriatr Psychiatry. 2005; 20: 523-530
The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: Systematic review and meta-analysis.
J Affect Disord. 2016; 190: 264-271
Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease.
Am J Geriatr Psychiatry. 2014; 22: 1642-1651
A systematic review of neuropsychiatric symptoms in mild cognitive impairment.
J Alzheimers Dis. 2009; 18: 11-30
Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment.
Psychol Med. 2013; 43: 911-920
Neuropsychiatric disturbances in Alzheimer’s disease: what have we learned from neuropathological studies?.
Cur Alzheimer Res. 2016; 13: 1145-1164
Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects.
Ann Neurol. 2009; 65: 403-413
MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults.
Neurology. 2012; 78: 84-90
MRI and CSF biomarkers in normal, MCI, and AD subjects predicting future clinical change.
Neurology. 2009; 73: 294-301
Trajectories of depressive symptoms and their relationship to the progression of dementia.
J Affect Disord. 2017; 222: 146-152
Cerebrospinal fluid Alzheimer markers in depressed elderly subjects with and without Alzheimer’s disease.
Dement Geriatr Cogn Dis Extra. 2012; 2: 48-56
Plasma biomarkers of depressive symptoms in older adults.
Transl Psychiatry. 2012; 2: e65
Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment.
Acta Psychiatr Scand. 2015; 131: 139-147
Neuropsychological and behavioural correlates of CSF biomarkers in dementia.
Neurochem Int. 2006; 48: 286-295
Cerebrospinal fluid biomarkers for neuropsychological symptoms in early stage of late-onset Alzheimer’s disease.
Int J Neurosci. 2015; 125: 747-754
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI).
Neurobiol Aging. 2017; 53: 1-10
Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer’s disease.
Dement Geriatr Cogn Dis. 2008; 25: 559-563
Beyond memory: a focus on the other neuropsychiatric symptoms of dementia.
Am J Geriatr Psychiatry. 2015; 23: 115-118
Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature.
Dement Geriatr Cogn Dis. 2008; 25: 115-126
The Dutch Parelsnoer Institute-Neurodegenerative diseases; methods, design and baseline results.
BMC Neurol. 2014; 14: 254
“Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician.
J Psychiatr Res. 1975; 12: 189-198
Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the Auspices of Department of Health and Human Services Task Force on Alzheimer’s disease.
Neurology. 1984; 34: 939-944
Mild cognitive impairment as a diagnostic entity.
J Intern Med. 2004; 256: 183-194
The Neuropsychiatric Inventory comprehensive assessment of psychopathology in dementia.
Neurology. 1994; 44: 2308
Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory.
J Neuropsychiatry Clin Neurosci. 2000; 12: 233-239
Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study.
Arch Gen Psychiatry. 2008; 65: 1193-1198
Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.
JAMA. 2002; 288: 1475-1483
The Alzheimer’s Disease Neuroimaging Initiative (ADNI): MRI methods.
J Magn Reson Imaging. 2008; 27: 685-691
Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia.
Hum Brain Mapp. 2014; 35: 4916-4931
Neuroimage. 2005; 26: 839-851
Team R Core: A language and environment for statistical computing. 2016.
How and why criteria defining moderators and mediators differ between the Baron & Kenny and MacArthur approaches.
Health Psychol. 2008; 27: S101
How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors.
Am J Psychiatry. 2001; 158: 848-856
The difficult distinction between affective disorders and mild cognitive deterioration. Neuropsychiatric Symptoms of Cognitive Impairment and Dementia.
Affective symptoms and AT(N) biomarkers in mild cognitive impairment and Alzheimer’s disease: a systematic literature review.
Neurosci Biobehav Rev. 2019; 107: 346-359
Depression and risk of developing dementia.
Nat Rev Neurol. 2011; 7: 323-331
Assessment and management of behavioral and psychological symptoms of dementia.
BMJ. 2015; 350: h369
Late-life anxiety and cognitive impairment: a review.
Am J Geriatr Psychiatry. 2008; 16: 790-803
Amyloid imaging with [(18)F]florbetapir in geriatric depression: early-onset versus late-onset.
Int J Geriatr Psychiatry. 2015; 30: 720-728
Neuropsychiatric signs and symptoms of Alzheimer’s disease: new treatment paradigms.
Alzheimers Dement TRCI. 2017; 3: 440-449